<DOC>
	<DOC>NCT02609633</DOC>
	<brief_summary>This interventional, 6-month post-marketing study is designed to evaluate the change in diabetes-related distress among parents/caregivers of school-age children and adolescents with type 1 diabetes (T1D) who are receiving multiple daily injections (MDI) therapy. Investigational sites will be assigned using cluster randomization, with approximately 10 to 20 children at each site. In order to maintain a true control group for comparison, the investigational sites will be randomly assigned to the Accu-Chek(R) Connect diabetes management system (DMS) or usual care/continued use of current DMS devices.</brief_summary>
	<brief_title>Accu-Chek Connect at School (CATS) Pediatric Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Children or adolescents, aged 6 to 18 years Diagnosis of T1D for at least 3 months Currently managed with insulin MDI therapy Attending fullday school schedule in Grade K through 12 Able to provide SMBG data minimum of one month prior to study start Currently using a compatible Smartphone with ability to download the ACCUCHEK Connect System App accordingly OR ability to utilize Smartphone and ACCUCHEK Connect System App as provided for use in study Parent/caregiver and adolescents 18 years of age to provide written informed consent Children 7 to 17 years to provide ageappropriate child assent Parent/caregiver currently using a compatible Smartphone with ability to receive SMS/MMS messages Able to read/write in English and comply with study procedures, including provision of selfmonitoring blood glucose (SMBG) data at least 1 month prior to the study Current or planned use of continuous subcutaneous insulin infusions during the study period Use of continuous glucose monitoring or a remote datasharing system/device (i.e. NightScout, DexCom Share, Medtronic Connect) during the study Pregnancy Clinically significant medical condition(s) such as anemia, major organ system disease, infection, psychosis, or cognitive impairment Requirement for chronic steroids, immunomodulatory medication, or chemotherapy in adrenal suppressive doses Visual impairment preventing use of the AccuChek Connect system Parent/caregiver is an investigator, general practitioner, practice staff, pharmacist, research assistant, or other staff or relative of those directly involved in the study</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>